恆指升幅擴至逾300點重越29,200 美團及百威亞太續漲4%-5%
美國總統拜登與兩黨參議員就過萬億美元基建新方案達共識,美股昨晚全面升近0.6%-1%,道指回升逾300點,標普回升0.6%再破頂,納指更連續三天破頂。亞太區股市全面造好,日經及臺股升0.8%及0.9%;滬指及深成升近0.8%及近1.1%,半日收3,594及14,943。
港股今早在高開120點或0.4%報29,002,升幅擴至331點或近1.2%報29,213,成交額705億元。
藍籌股普遍造好,百威亞太(01876.HK)升幅最大,股價三連漲兼一舉升破5條主要移動平均線(24.99-25.6元),最高見25.85元,現造25.7元,續升4.9%。美團(03690.HK)三連升,今早高開0.6%升幅擴大,重越百天線(320.1元),現造328元,升4%。騰訊(00700.HK)續升1.7%報593元,股價重越10天及牛熊線(591.1元)。阿裏(09988.HK)三連漲,今早股價重越50天線(214.7元),最高見214.8元。
國際油價屢創逾兩年高,「兩桶油」中石油(00857.HK)及中海油(00883.HK)續升約2.5%,前者連續第四天探頂高見3.91元逾年半高,後者報9.19元。
此外,藥明生物(02269.HK)今早曾突破本週盤中所創上市高位142.6元,最高見143.1元,現造140.5元,回升1.2%。阿裏健康(00241.HK)承昨天升勢(重越10天線),今早再升2.3%報17.86元。出口股創科(00669.HK)回升2.6%報135.8元,股價曾重越10天線(136元),高見136.7元。
金融股以港交所(00388.HK)表現最好,股價曾高見474.4元,現升2.7%,重越10天及20天線。中國平安(02318.HK)及國壽(02628.HK)也升逾1%,前者股價重越10天線(78.15元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.